WEST PHARMACEUTICAL SERVICES, INC. Repayments of Other Long-term Debt
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Repayments of Other Long-term Debt of $169.00 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-10-24.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfOtherLongTermDebt · last filed 2024-10-24
- WEST PHARMACEUTICAL SERVICES, INC. repayments of other long-term debt for the quarter ending 2024-09-30 was $132.90M, a 22050.00% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. repayments of other long-term debt for the quarter ending 2024-06-30 was $35.50M, a 7000.00% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. repayments of other long-term debt for the quarter ending 2024-03-31 was $600.00K, a 0.00% change year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. repayments of other long-term debt for the quarter ending 2023-12-31 was $600.00K, a 0.00% change year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. repayments of other long-term debt for fiscal 2023 was $2.30M, a 94.81% decline from fiscal 2022.
- WEST PHARMACEUTICAL SERVICES, INC. repayments of other long-term debt for fiscal 2022 was $44.30M, a 1913.64% increase from fiscal 2021.
- WEST PHARMACEUTICAL SERVICES, INC. repayments of other long-term debt for fiscal 2021 was $2.20M.
| Period end | Repayments of Other Long-term Debt 3 month | Repayments of Other Long-term Debt 6 month | Repayments of Other Long-term Debt 9 month | Repayments of Other Long-term Debt 12 month |
|---|---|---|---|---|
| 2024-09-30 | $132.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-24 | $168.40M derived: sum of 2 quarters · filed 2024-10-24 | $169.00M 10-Q · filed 2024-10-24 | $169.60M derived: sum of 4 quarters · filed 2024-10-24 |
| 2024-06-30 | $35.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-25 | $36.10M 10-Q · filed 2024-07-25 | $36.70M derived: sum of 3 quarters · filed 2024-07-25 | $37.30M derived: sum of 4 quarters · filed 2024-10-24 |
| 2024-03-31 | $600.00K 10-Q · filed 2024-04-25 | $1.20M derived: sum of 2 quarters · filed 2024-04-25 | $1.80M derived: sum of 3 quarters · filed 2024-10-24 | $2.30M derived: sum of 4 quarters · filed 2024-10-24 |
| 2023-12-31 | $600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $1.20M derived: sum of 2 quarters · filed 2024-10-24 | $1.70M derived: sum of 3 quarters · filed 2024-10-24 | $2.30M 10-K · filed 2024-02-20 |
| 2023-09-30 | $600.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-24 | $1.10M derived: sum of 2 quarters · filed 2024-10-24 | $1.70M 10-Q · filed 2024-10-24 | $2.30M derived: sum of 4 quarters · filed 2024-10-24 |
| 2023-06-30 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-25 | $1.10M 10-Q · filed 2024-07-25 | $1.70M derived: sum of 3 quarters · filed 2024-07-25 | $44.30M derived: sum of 4 quarters · filed 2024-07-25 |
| 2023-03-31 | $600.00K 10-Q · filed 2024-04-25 | $1.20M derived: sum of 2 quarters · filed 2024-04-25 | $43.80M derived: sum of 3 quarters · filed 2024-04-25 | $44.30M derived: sum of 4 quarters · filed 2024-04-25 |
| 2022-12-31 | $600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $43.20M derived: sum of 2 quarters · filed 2024-02-20 | $43.70M derived: sum of 3 quarters · filed 2024-02-20 | $44.30M 10-K · filed 2024-02-20 |
| 2022-09-30 | $42.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $43.10M derived: sum of 2 quarters · filed 2023-10-26 | $43.70M 10-Q · filed 2023-10-26 | $44.80M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $1.10M 10-Q · filed 2023-07-27 | $2.20M derived: sum of 3 quarters · filed 2024-02-20 | $2.20M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | $600.00K 10-Q · filed 2023-04-27 | $1.70M derived: sum of 2 quarters · filed 2024-02-20 | $1.70M derived: sum of 3 quarters · filed 2024-02-20 | $2.20M derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $1.10M derived: sum of 2 quarters · filed 2024-02-20 | $1.60M derived: sum of 3 quarters · filed 2024-02-20 | $2.20M 10-K · filed 2024-02-20 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $500.00K derived: sum of 2 quarters · filed 2022-10-27 | $1.10M 10-Q · filed 2022-10-27 | |
| 2021-06-30 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-28 | $1.10M 10-Q · filed 2022-07-28 | ||
| 2021-03-31 | $600.00K 10-Q · filed 2022-04-28 | |||
| 2020-09-30 | $600.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $1.10M derived: sum of 2 quarters · filed 2021-10-28 | $1.70M 10-Q · filed 2021-10-28 | |
| 2020-06-30 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $1.10M 10-Q · filed 2021-07-30 | ||
| 2020-03-31 | $600.00K 10-Q · filed 2021-04-30 | |||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-23 | $0.00 10-Q · filed 2020-10-23 | ||
| 2019-06-30 | $0.00 10-Q · filed 2020-07-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |